- •Chapter 1
- •Ocular Adnexal Lymphoproliferative
- •1.1 Pathogenesis
- •1.2 Chronic Antigen Stimulation
- •1.3 Immunosuppression
- •1.4 Pathology
- •1.5 Cytogenetics
- •1.6 Clinical Features
- •1.7 Imaging Findings
- •1.8 Staging
- •1.9 Positron Emission Tomography
- •1.10 Treatment
- •1.11 Follicular Lymphoma
- •1.12 Mantle Cell Lymphoma
- •1.13 Radiotherapy
- •1.14 Chemotherapy
- •1.15 Immunotherapy
- •1.16 Radioimmunotherapy
- •1.17 Outcome
- •1.18 The Future
- •References
- •Chapter 2
- •2.1 General Introduction
- •2.2 The Aging Process and Facial Analysis
- •2.3 Endoscopic Brow Lift
- •2.3.1 Introduction
- •2.3.2 Endoscopic Browlift Anesthesia Pearls
- •2.3.4 Endoscopic Browlift Postoperative Care Pearls
- •2.4 Upper Blepharoplasty
- •2.4.1 Introduction
- •2.4.2 Patient Evaluation
- •2.4.3 Upper Blepharoplasty Anesthesia Pearls
- •2.4.4 Upper Blepharoplasty Surgical Procedure Pearls
- •2.5 Lower Blepharoplasty, Fillers, and Midface Augmentation
- •2.5.1 Introduction
- •2.5.2 Patient Evaluation
- •2.5.3 Lower Blepharoplasty Anesthesia Pearls
- •2.5.4 Lower Blepharoplasty Surgical Procedure Pearls
- •References
- •Chapter 3
- •3.1 Introduction
- •3.2 What Is the Diagnosis?
- •3.2.1 Pitfalls of Diagnosis
- •3.2.2 A Diagnostic Corticosteroid Trial?
- •3.2.3 The Question of Biopsy
- •3.3 Treatment
- •3.3.1 Corticosteroids
- •3.3.2 Radiation
- •3.3.3 Other Agents
- •3.4 Special Circumstances
- •3.4.1 Pediatric IOIS
- •3.4.2 Sclerosing Pseudotumor
- •3.4.3 Tolosa–Hunt Syndrome
- •References
- •Chapter 4
- •4.1 Introduction
- •4.2 Embryology, Anatomy, Physiology, and Pathophysiology of the Canalicular System
- •4.3 Infective Causes
- •4.3.1 Periocular Herpes Simplex Infection
- •4.3.2 Bacterial Canaliculitis
- •4.4.1 Lichen Planus
- •4.4.2 Ocular Cicatricial Pemphigoid
- •4.5 Iatrogenic Causes
- •4.5.1 Systemic Drugs
- •4.5.1.2 Docetaxel (Taxotere)
- •4.5.2 Radiotherapy
- •4.5.3 Topical Ophthalmic Treatments
- •4.5.3.2 Mitomycin C (MMC) Therapy
- •4.5.4 Lacrimal Stents and Plugs
- •4.6 The Surgical Approach to Managing Canalicular Disease
- •4.6.1 Surgical Technique for Dacryocystorhinostomy with Retrograde Canaliculostomy
- •References
- •Chapter 5
- •5.1 Introduction
- •5.2 Nomenclature
- •5.3 Clinical Manifestations of NF1
- •5.4 Orbitofacial Tumors in NF1
- •5.4.2 Malignant Peripheral Nerve Sheath Tumors
- •5.4.3 Optic Pathway Gliomas
- •5.5 Genetics
- •5.5.1 The NF1 Gene
- •5.5.2 Overlapping NF1-Like Phenotype (SPRED1)
- •5.6.1 Introduction
- •5.7 Surgical Management of Orbitofacial Tumors in NF1
- •5.7.1 Introduction
- •5.7.2 Timing of Surgery
- •5.7.3 Periorbital Involvement
- •5.7.3.1 The Upper Eyelid
- •5.7.3.2 The Lower Eyelid and Midface
- •5.7.4 Orbital Involvement
- •5.7.4.1 Proptosis
- •5.7.4.3 Proptosis Due to Optic Nerve Glioma
- •5.7.4.4 Orbital Enlargement with Dystopia and Hypoglobus
- •5.8 The Natural History of NF1 Tumor Growth from Birth to Senescence
- •References
- •Chapter 6
- •6.1 Introduction
- •6.2 Surgical Anatomy of the Lacrimal Drainage System
- •6.3 Basic Diagnostics for Disorders of the Lacrimal Drainage System
- •6.4 Selective Lacrimal Sac Biopsy in External Dacryocystorhinostomy
- •6.5.1 Case A
- •6.5.2 Case B
- •6.5.3 Case C
- •6.5.4 Case D
- •6.5.5 Case E
- •6.5.6 Case F
- •6.5.7 Case G
- •References
- •Chapter 7
- •7.1 Introduction
- •7.2 Patients and Methods
- •7.2.1 Patients
- •7.2.2 Examination
- •7.3 Results
- •7.3.1 Patient Data
- •7.3.3 Family History
- •7.3.4 Pregnancy History
- •7.3.5 Birth
- •7.3.6 Associated Systemic and Ocular Diseases
- •7.3.8 Neuroradiological Findings (Brain MRI)
- •7.3.9 Nasolacrimal System Findings
- •7.4 Discussion
- •7.4.1 Patients
- •7.4.2 Obstetric and Family History
- •7.4.3 Associated Pathologies
- •7.4.3.1 Ophthalmological Findings in Unilateral Disease
- •7.4.3.2 Neuroradiological Findings
- •7.4.3.3 Systemic Diseases
- •7.4.3.4 Nasolacrimal Duct Findings
- •7.5 Conclusions
- •References
- •Chapter 8
- •8.1 Introduction
- •8.2 Evaluation of Complicated Ptosis
- •8.2.1 Compensatory Eyebrow Elevation
- •8.2.3 Innervation Patterns of the Frontalis Muscle
- •8.2.4 Checklist of Preoperative Evaluation of Complicated Ptosis
- •8.3 Surgical Technique of Levator Muscle Recession
- •8.3.1 Principle
- •8.3.2 Approach to the Levator
- •8.3.3 Partial Levator Recession
- •8.3.4 Total Levator Recession
- •8.3.6 Undercorrection and Overcorrection
- •8.4 Surgical Technique of Brow Suspension
- •8.4.1 Materials for Brow Suspension
- •8.4.1.1 Nonautogenous Materials
- •8.4.1.2 Autogenous Fascia Lata
- •8.4.2 Our Technique of Harvesting Autogenous Fascia Lata
- •8.4.3 Mechanical Principals of Brow Suspension
- •8.4.4 Upper Lid Approach
- •8.4.5 Fascia Implantation
- •References
- •Chapter 9
- •Modern Concepts in Orbital Imaging
- •9.1 Computerized Tomography
- •9.2 Three-Dimensional Imaging
- •9.3 Magnetic Resonance Imaging
- •9.3.1 The T1 Constant
- •9.3.2 The T2 Constant
- •9.3.3 Creating the MR Image
- •9.4 Imaging of Common Orbital Lesions
- •9.4.1 Adenoid Cystic Carcinoma
- •9.4.2 Cavernous Hemangioma
- •9.4.3 Dermoid Cyst
- •9.4.4 Fibrous Dysplasia
- •9.4.5 Lymphangioma
- •9.4.6 Lymphoma
- •9.4.7 Myositis
- •9.4.8 Optic Nerve Glioma
- •9.4.9 Pseudotumor
- •9.4.10 Rhabdomyosarcoma
- •9.6 Positron Emission Tomography
- •9.7 Orbital Ultrasound
- •9.7.1 Physics and Instrumentation
- •9.7.1.1 Topographic Echography
- •9.7.1.2 Quantitative Echography
- •9.7.1.3 Kinetic Echography
- •9.7.2 Extraocular Muscles
- •9.7.3 Optic Nerves
- •References
- •Chapter 10
- •10.1 Introduction
- •10.3 Etiology
- •10.4 Microbiology
- •10.5 Changing Pathogens and Resistance
- •10.5.2 Orbital MRSA
- •10.6 Evaluation of Orbital Cellulitis
- •10.7 Medical Treatment of Orbital Cellulitis
- •10.8 Surgical Treatment of Orbital Cellulitis
- •10.9 Prevention of Orbital Cellulitis After Orbital Fracture
- •References
- •Chapter 11
- •11.1 Clinical Picture
- •11.1.1 Clinical Phases
- •11.2 Ocular Complications
- •11.3 Investigation
- •11.3.1 Angiography
- •11.4 Management
- •11.4.1 Active Nonintervention
- •11.4.2 Indications for Treatment
- •11.5 Modalities of Treatment
- •11.5.1 Steroids
- •11.5.1.1 Topical Steroids
- •11.5.1.2 Intralesional Corticosteroid Injection
- •11.5.1.3 Oral Corticosteroids
- •11.5.2 Interferon-Alfa
- •11.5.3 Vincristine
- •11.5.4 Laser
- •11.5.5 Embolization
- •11.5.6 Surgery
- •References
- •Chapter 12
- •12.1 Introduction
- •12.2 Epidemiology
- •12.3 Biological Behavior and Timing of Metastasis
- •12.4 Lateralization
- •12.5 Localization
- •12.6 Clinical Features
- •12.7 Imaging and Patterns of Orbital Metastatic Disease
- •12.8 Biopsy
- •12.9 Common Types of Orbital Metastases
- •12.9.1 Breast Carcinoma
- •12.9.2 Lung Carcinoma
- •12.9.3 Prostatic Cancer
- •12.9.4 Melanoma
- •12.9.5 Carcinoid Tumor
- •12.11 Treatment
- •12.11.1 Radiotherapy
- •12.11.2 Chemotherapy
- •12.11.3 Hormonal Therapy
- •12.11.4 Surgery
- •12.12 Prognosis and Survival
- •References
- •Chapter 13
- •13.1 Introduction
- •13.2 Rituximab
- •13.3 Yttrium-90-Labeled Ibritumomab Tiuxetan
- •13.4 Imatinib Mesylate
- •13.5 Cetuximab
- •References
- •Chapter 14
- •14.1 Introduction
- •14.2 Porous Orbital Implants
- •14.3 Orbital Implant Selection in Adults
- •14.4 Orbital Implant Selection in Children
- •14.5 Volume Considerations in Orbital Implant Selection
- •14.7 Which Wrap to Use
- •14.8 To Peg or Not to Peg Porous Implants
- •14.9 Summary
- •References
- •Chapter 15
- •15.1 Introduction
- •15.2 Etiology and Presentation
- •15.2.1 Etiology of Orbital Volume Loss
- •15.2.2 Etiology of Periorbital Volume Loss
- •15.2.3 Features of Orbital Volume Loss
- •15.2.4 Features of Periorbital Volume Loss
- •15.3 Background to Injectable Soft-Tissue Fillers
- •15.3.1 Historical Perspective on Volume Replacement
- •15.4 Types of Injectable Soft-Tissue Filler
- •15.4.1 Collagen Fillers
- •15.4.2 Hyaluronic acid Fillers
- •15.5 Treatment Areas
- •15.5.1 Orbit
- •15.5.2 Upper Eyelid and Brow
- •15.5.3 Tear Trough
- •15.5.4 Temple and Brow
- •15.6 Other Periorbital Uses of Injectable Soft-Tissue Fillers
- •15.6.1 Upper Eyelid Loading
- •15.6.2 Lower Eyelid Elevation
- •15.6.3 Treatment of Cicatricial Ectropion
- •15.7 Future Developments
- •References
158 |
10 Management of Periorbital Cellulitis in the 21st Century |
|
|
Summary for the Clinician |
||
|
|
|
|
|
|
|
■ Intravenous antibiotics e ective against orbital |
||
|
|
pathogens in vitro may be ine ective in the clini- |
||
10 |
||||
|
cal treatment of advanced orbital cellulitis. |
|||
|
|
■ Harris confirmed the tendency toward culture- |
||
|
|
negative or single-isolate infections in children |
||
|
|
younger than 9 years that responded to antibi- |
||
|
|
otic therapy alone. |
||
|
|
■ Experience gleaned from these studies has clas- |
||
|
|
sified the need for surgical intervention into |
||
|
|
emergent, urgent, and expectant groups. |
||
|
|
■ Emergency drainage was deemed appropriate |
||
|
|
for cases of optic nerve or retinal compromise |
||
|
|
secondary to induced mass e ect. |
||
|
|
■ Virtually all patients older than 14 years will |
||
|
|
have a complex, polymicrobial infection, which |
||
|
|
should be drained more urgently as antibiotics |
||
|
|
are less likely to be e ective. |
||
|
|
■ Patients younger than 9 years can usually be |
||
|
|
observed given the predilection to simple infec- |
||
|
|
tions in this population and the typical response |
||
|
|
to antibiotics alone. |
||
|
|
■ For observation, the following need to be absent: |
||
|
|
age of 9 years or older, frontal sinusitis, nonme- |
||
|
|
dial or large subperiosteal abscess, gas within |
||
|
|
abscess on CT or other suspicion of anaerobic |
||
|
|
infection, recurrence after prior surgical inter- |
||
|
|
vention, radiologic evidence of chronic sinusitis, |
||
|
|
acute optic nerve or retinal compromise, or den- |
||
|
|
tal etiology of infection predisposing to anaero- |
||
|
|
bic infiltration. |
||
|
|
■ The only universal rule in the current literature |
||
|
|
is that the decision to intervene surgically must |
||
|
|
rest on the physician’s opinion, clinical judg- |
||
|
|
ment, and knowledge of the potential course of |
||
|
|
orbital cellulitis. |
|
|
|
|
|
||
|
|
|
|
|
10.9Prevention of Orbital Cellulitis After Orbital Fracture
Orbital cellulitis is a rare side e ect of an orbital fracture [2]. When cellulitis does result from orbital blowout fracture, one mechanism is thought to be the formation of anatomical communications between the fractured sinuses and orbit [19]. However, the sinus is a sterile space. These new anatomical communications between the orbit and sinus exist for the life of the patient. As a
result, cellulitis may arise from several days to over 20 years after initial orbital injury. In addition, orbital decompression is a common procedure, representing a controlled fracture of the sinus, and has a very low incidence of postoperative orbital infection. Further, sinuses are protected by lymphocytes, interferons, and alkaline mucus that circulates every 10 min. Logically, sinusitis in these fracture patients has been associated with the development of subsequent orbital cellulitis, albeit rarely, especially in the early healing phases weeks to months after the injury. The role for prophylactic antibiotics has never been established. The potential orbital cellulitis following fracture should hold no clinical importance in patients not su ering from sinusitis.
Given the very low incidence of cellulitis attributable to blowout fractures, the prolonged healing of sinus mucosa compared to the short nature of antibiotic treatment, the possibility of a long lag period between injury and orbital cellulitis, and previous case reports showing no obvious benefit from the prophylaxis of orbital cellulitis following blowout fracture, physicians should consider not prescribing antibiotics for orbital fractures. The practice thereof may be unnecessarily costly, time consuming, and potentially harmful to the patients in this era of antibiotic resistance. Patients with active sinus disease at the time of their fracture should still be treated with oral antibiotics, even though studies show they do not always prevent infection.
Summary for the Clinician
■It is important to consider MRSA as a cause of infection when choosing appropriate antibiotic therapy.
■CT scan of the orbit and sinus is a very helpful tool when determining the best course of treatment.
■Antibiotics are most e ective as single therapy in young children, whereas antibiotics and surgery are more often needed in teenagers and adults.
■MRSA infections of the orbit require aggressive management with appropriate antibiotics and early surgery when indicated.
■Atypical infections like orbital cellulitis not arising from the sinus or infections that potentially may spread to adjacent areas (like frontal sinusitis with orbital involvement and possible intracranial spread) should be treated surgically in a more urgent matter.
References
1.Anari S, Karagama YG, Fulton B, Wilson JA (2005 Jan) Neonatal disseminated methicillin-resistant Staphylococcus aureus presenting as orbital cellulitis. J Laryngol Otol 119(1):64–67
2.Ben Simon GJ, Bush S, Selva D, McNab AA (2005 Nov) Orbital cellulitis: a rare complication after orbital blowout fracture. Ophthalmology 112:2030–2034
3.Braun L, Craft D, Williams R, et al (2005) Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr Infect Dis J 24:622–626
4.Cannon PS, Keag DM, Radford R (2008 Feb 29) Our experience using primary oral antibiotics in the management of orbital cellulitis in a tertiary referral centre. Eye (Epub ahead of print)
5.Chambers HR (2001) The changing epidemiology of Staphylococcus aureus? Emerging Infect Dis 7(2):178–182
6.Chandler JR, Langenbrunner DJ, Stevens ER (1970) The pathogenesis of orbital complications in acute sinusitis. Laryngoscope 80:1414–1428
7.Chaudhry IA, Shamsi FA, Elzaridi E, Al-Rashed W, Al-Amri A, Arat YO (2008) Inpatient preseptal cellulitis: experience from a tertiary eye care centre. Br J Ophthalmol 92(10):1337–1341
8.Ho CF, Huang YC, Wang CJ, et al (2007) Clinical analysis of computed tomography-staged orbital cellulitis in children. J Microbiol Immunol Infect 40
9.Chiang RK, Rapuano CJ (2002) Recurrent methicillinresistant Staphylococcus aureus wound ulcer after clearcornea cataract surgery. CLAO J 28:109–110
10.Connell B, Kamal Z, McNab AA (2001) Fulminant orbital cellulitis with complete loss of vision. Clin Exp Ophthalmol 29:260–261
11.Deurenberg RH, Stobberingh EE (2009 Mar) The molecular evolution of hospitaland community-associated methicillin-resistant Staphylococcus aureus. Curr Mol Med 9(2):100–115
12.Devrim I, Kanra G, Kara A, et al (2008 May–Jun) Preseptal and orbital cellulitis: 15-year experience with sulbactam ampicillin treatment. Turk J Pediatr 50(3):214–218
13.Dhariwal DK, Kittur MA, Farrier JN, Sugar AW, Aird DW, Laws DE (2003) Post-traumatic orbital cellulitis. Br J Oral Maxillofacial Surg 41:21–28
14.Diep BA, Chambers HF, Graber CJ, et al (2008) Emergence of multidrug-resistant, community-associated, methicil- lin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 148(4):249–257
15.Donnenfeld ED, O’Brien TP, Solomon R, et al (2003) Infectious keratitis after photorefractive keratectomy. Ophthalmology 110:743–747
References 159
16.Forster W, Becker K, Hungermann D, Busse H (2002) Methicillin-resistant Staphylococcus aureus keratitis after excimer laser photorefractive keratectomy. J Cataract Refract Surg 28:722–724
17.Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F (2005) High prevalence of methicil- lin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 45:311–320
18.Garcia GH, Harris GJ (2000) Criteria for nonsurgical management of subperiosteal abscess of orbit: analysis of outcomes 1988–1998. Ophthalmol 107:1454–1456
19.Goldfarb MS, Ho man DS, Rosenberg S (1987) Orbital cellulitis and orbital fractures. Ann Ophthalmol 19:97–99
20.Goodyear PWA, Firth AL, Strachan DR, Dudley M (2004) Periorbital swelling: the important distinction between allergy and infection. Emerg Med J 21:240–242
21.Harris GJ (1994) Subperiosteal abscess of the orbit. Age as a factor in the bacteriology and response to treatment. Ophthalmology 101(3):585–595
22.Herold BC, Immergluck LC, Maranan MC, et al (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593–598
23.Ho CF, Huang YC, Wang CJ, et al (2007) Clinical analysis of computed tomography-staged orbital cellulitis in children. J Microbiol Immunol Infect 40:518–524
24.Howe L, Jones NS (2004) Guidelines for the management of periorbital cellulitis/abscess. Clin Otolaryngol 29:725–728
25.Ingraham HJ, Ryan ME, Burns JT, Shuhart D, Tenedios G, Malone W, et al (1995 Aug) Streptococcal preseptal cellulitis complicated by the toxic Streptococcus syndrome. Ophthalmology 102(8):1223–1226
26.Jakobiec FA, Bilyk JR, Font RL (1990) Orbit. In: Spencer WH (ed) Ophthalmic pathology, Vol 4, 4th ed. Saunders, Philadelphia, pp. 2861–2872
27.Kannoth S, Iyer R, Thomas SV, Furtado SV, Rajesh BJ, Kesavadas C, et al (2007 May 15) Intracranial infectious aneurysm: presentation, management and outcome. J Neurol Sci 256(1–2):3–9. (Epub 23 Mar 2007)
28.Kato T, Hayasaka S (1998) Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulasenegative staphylococci from conjunctivas of preoperative patients. Jpn J Ophthalmol 42:461–465
29.Kazakova SV, Hageman JC, Matava M, et al (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352:468–475
30.Kikkawa DO, Heinz GW, Martin RT (2002) Orbital cellulitis and abscess secondary to dacryocystitis. Arch Ophthalmol 120:1096–1099
31.Kotlus BS, Rodgers IR, Udell IJ (2005) Dacryocystitis caused by community-onset methicillin-resistant Staphylococcus aureus. Ophthal Plast Reconstr Surg 25:371–375
160 |
10 Management of Periorbital Cellulitis in the 21st Century |
32.Kronish JW, Johnson TE, Gilberg SM, Corrent GF, McLeish WM, Scott KR (1996 Sep) Orbital infections in patients with human immunodeficiency virus infection. Ophthalmology 103(9):1483–1492
10 33. Layton MC, Hierholzer WJ, Jr, Patterson JE (1995) The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol 16:12–17
34.Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y, Otto M (2009) Evolution of virulence in epidemic community-associated methicillin-resis- tant Staphylococcus aureus. Proc Natl Acad Sci USA 106(14):5883–5888
35.Liu IT, Kao SC, Wang AG, et al (2006) Preseptal and orbital cellulitis: a 10-year review of hospitalized patients. J Chin Med Assoc 69(9):415–422
36.McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC (2003) Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41:5113–5120
37.McKinley SH, Yen MT, Miller AM, et al (2007) Microbiology of pediatric orbital Ccllulitis. Am J Opthalmol 144: 497–501
38.Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al (2006; Aug) Methicillinresistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666–674
39.Moroney SM, Heller LC, Arbuckle J, Talavera M, Widen RH (2007) Staphylococcal cassette chromosome mec and Panton–Valentine leukocidin characterization of methicil- lin-resistant Staphylococcus aureus clones. J Clin Microbiol 45(3):1019–1021
40.Orekoya AM, McMoli TE (1987 Mar) Morbidity and mortality from orbital cellulitis. East Afr Med J 64(3):190–193
41.Oshima Y, Ohji M, Inoue Y, et al (1999) Scleral buckling: methicillin-resistant Staphylococcus aureus infections after scleral buckling procedures for retinal detachments associated with atopic dermatitis. Ophthalmol 106:142–147
42.Oshitari K, Hirakata A, Okada AA, Hida T, Oda H, Miki D, et al (2003 Oct) Vitrectomy for endophthalmitis after cataract surgery [in Japanese]. Nippon Ganka Gakkai Zasshi 107(10):590–596.
43.Osmoti AE, Ogbedo E (2007 Mar) Ophthalmic mortality in a tertiary centre in Nigeria. Niger Postgrad Med J 14(1): 54–56
44.Paterson AW, Barnard NA, Irvine GH (1994) Naso-orbital fracture leading to orbital cellulitis and visual loss as a complication of chronic sinusitis. Br J Oral Maxillofacial Surg 30:80–82
45.Pereira KD, Mitchell RB, Younis RT, Lazar RH (1997) Management of medial subperiosteal abscess of the orbit in children—a 5 year experience. Int J Pediatr Otorhinol 38:247–254
46.Rubinfeld RS, Negvesky GJ (2001) Methicillin-resistant Staphylococcus aureus ulcerative keratitis after laser in situ keratomilieusis. J Cataract Refract Surg 27:1523–1525
47.Rudd JC, Morshifar M (2001) Methicillin-resistant Staphylococcus aureus keratitis after laser in situ keratomileusis. J Cataract Refract Surg 27:471–473
48.Rutar T, Chambers HF, Crawford JB, Perdreau-Remington F, Zwick OM, Karr M, et al (2006) Ophthalmic manifestations of infections caused by the USA300 clone of commu- nity-associated methicillin-resistant Staphylococcus aureus. Ophthalmology 113(8):1455–1462
49.Rutar T, Zwick OM, Cockerham KP, Horton JC (2005) Bilateral blindness from orbital cellulitis caused by com- munity-acquired methicillin-resistant Staphylococcus aureus. Am J Ophthalmol 140(4):740–742
50.Shanmuganathan VA, Armstrong M, Buller A, Tullo AB (2005) External ocular infections due to methicillin-resis- tant Staphylococcus aureus (MRSA). Eye 19:284–291
51.Solomon R, Donnenfeld ED, Perry HD, Biser S (2003) Bilateral methicillin-resistant Staphylococcus aureus keratitis in a medical resident following an uneventful bilateral photorefractive keratectomy. Eye Contact Lens 29:187–189
52.Sotozono C, Inagaki K, Fujita A, et al (2002) Methicillinresistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.Cornea 21:S94–S101
53.Starkey CR, Steele RW (2001 Oct) Medical management of orbital cellulitis. Pediatr Infect Dis J 20(10):1002–1005
54.Strandén AM, Frei R, Adler H, Flückiger U, Widmer AF (2009) Emergence of SCCmec Type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital. Infection 37(1):44–48
55.Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R (2008) Does antibiotic exposure increase the risk of meth- icillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 61:26–38
56.Uy HS, Tuano PM (2007 Mar) Preseptal and orbital cellulitis in a developing country. Orbit 26(1):33–37
57.Walker JC, Sandhu A, Pietris G (2002 Apr) Septic superior ophthalmic vein thrombosis. Clin Exp Ophthalmol 30(2): 144–146
58.Yen MT, Yen KG (2005 Sep) E ect of corticosteroids in the acute management of pediatric orbital cellulitis with subperiosteal abscess. Opthal Plast Reconstr Surg 21(5):363–6; discussion 366–367
